Pure Hospitality Solutions Files Year-End Disclosures With OTC Markets

About this update from Regenerative Medical Technology Group Inc.

[{"type":"text","content":"\n\n LAS VEGAS, NV, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Pure Hospitality Solutions, Inc. (OTC PINK: PNOW), the developer of multiple and diverse business ventures, relevant to Central America and the Caribbean, announced today that the Company has filed its year-end disclosures with the OTC Markets, keeping its current information designation. \n “The time has finally come…,” stated Melvin Pereira, President and CEO of Pure Hospitality Solutions, Inc. “We have filed these disclosures and handed all of our information to the auditors for them to finalize our audit. The auditing firm, after verifying all of our information, will then re-file our disclosures, audited, then send the information to the SEC (Securities and Exchange Commission) for filing. We have talked about accomplishing this endeavor for a long time now, and we are finally here!” According to management, these disclosures are the best yet in the Company’s history. With substantially increased revenues, an overall increase in inventory and a drastic reduction in debt, management feels that the Company is primed to make major moves in 2018. Furthermore, with an audit that is about to be completed, management feels that things will materialize more quickly than originally anticipated. Pereira continued, “I hope that all of our shareholders, noteholders, bashers and enthusiasts alike, all take the time to actually sit down and read these newly filed disclosures. The Company’s transformation that has occurred over the past year is truly significant – we are finally primed and ready to excel in the global markets. As an audited, SEC-Reporting Company, we see a lot of growth in our future, with a potential move to the bigger-board stock-exchanges.” Key takeaways from this filing include a substantial decrease in total liabilities, from $7,611,322 in 2016, to $2,958,548 as of year-end 2017, or a 61% total reduction in liabilities. Another major achievement accomplished in this filing – Gross Profit, which stood at $0 in 2016 [no profit], and totaled $24,432 as of year-end 2017. One of the most notable changes, however, includes a significant increase in Net Income, where the Company experienced a deficit of $4,338,870 in 2016 and a surplus of $230,630 for year-end 2017. Pereira concluded, “The numbe...

More updates from Regenerative Medical Technology Group Inc.